News

Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...
Mega Matrix Inc (MPU) is expected to report for 1Q. North West Co Inc (NWC.T) is expected to report $0.52 for 1Q. Oracle Corp (ORCL) is expected to report $1.18 for 4Q. Oxford Industries Inc (OXM) is ...
Fintel reports that on June 10, 2025, B of A Securities downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) from ...
Bank of America Securities analyst Jason Zemansky downgraded Keros Therapeutics, Inc. (NASDAQ:KROS) from Buy to Neutral, ...
BofA's Zemansky downgraded Keros to Neutral, citing limited near-term upside, cautious sentiment, and unresolved investor ...
Keros Therapeutics’ pledge to hand $375 million to shareholders has not been enough to appease activist investor demands to ...
After a major shareholder pushed back, Keros is returning half of its capital to investors in a move that Guggenheim analysts ...
Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...
Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing ...